NBC News21d
Tennessee woman accused of selling fake weight loss drugs as counterfeit concerns grow
Some people who used the counterfeit drugs reported rashes and other pain from the ... to dispense compounded versions of semaglutide and tirzepatide until shortages of the brand-name drugs ...
Compounding pharmacies can resume making tirzepatide as FDA reconsiders shortage
Tirzepatide was on the FDA’s drug shortage ... “We believe that this is a fair resolution in light of the agency’s rash ...
STAT28d
FDA confirms shortage of weight loss drug tirzepatide is over, gives compounders a grace period
The Food and Drug Administration on Thursday confirmed that a shortage of Eli Lilly’s obesity drug tirzepatide has been resolved, a move that will soon put a stop to companies making cheaper ...
UPI27d
FDA says shortage of GLP-1 drug tirzepatide is over
The U.S. Food and Drug Administration reissued a decision first made by the agency in October that a shortage of the diabetes/weight-loss med tirzepatide is over. Tirzepatide includes blockbuster ...
New York Post21d
FDA approves first medication for obstructive sleep apnea — which also promotes weight loss
The Dec. 20 announcement by the FDA revealed that Eli Lilly’s Zepbound (tirzepatide ... allergic reactions (typically fever and rash), burping, hair loss and gastroesophageal reflux disease.
Healio27d
FDA confirms end of tirzepatide shortage
After a second investigation, the FDA announced tirzepatide will no longer be on the agency’s drug shortage list. Dates were announced for distribution of compounded forms for the drugs to end.
Yahoo27d
The FDA says the Zepbound shortage is over. That's rattling the weight loss industry
The U.S. Food and Drug Administration announced Thursday that the shortage of tirzepatide — the active ingredient in Eli Lilly’s popular diabetes and weight-loss drugs Mounjaro and Zepbound ...
Yahoo22d
The shortage of popular weight loss drug tirzepatide is over, FDA says. Patients could see higher costs as a result.
Tirzepatide, the active ingredient in Zepbound and Mounjaro, is no longer in short supply, the FDA says. Cheaper versions of the drug, known as compounded tirzepatide, might be restricted in 2025 ...
Business Insider27d
End to tirzepatide shortage has read on Hims GLP-1 trajectory, says Leerink
Leerink notes that the FDA today declared an end to the tirzepatide shortage, which “seemingly begins the process of bringing the compounded GLP-1 market back to ‘normal’ behavior.” ...
Nasdaq1mon
Lilly's Zepbound® (tirzepatide) superior to Wegovy® (semaglutide) in head-to-head trial showing an average weight loss of 20.2% vs. 13.7%
Tirzepatide is commercialized for adults ... problems breathing or swallowing, severe rash or itching, fainting or feeling dizzy, or very rapid heartbeat. Low blood sugar (hypoglycemia).
Medscape23d
Obesity Drug Zepbound Approved for Obstructive Sleep Apnea
Tirzepatide, a dual glucagon-like peptide 1 ... hypersensitivity reactions (typically fever and rash), burping, hair loss, and gastroesophageal reflux disease. In an editorial accompanying ...